High impact science

We invest in companies addressing significant unmet needs in healthcare, which have the potential to deliver breakthrough treatments to patients.

Read more about our investment strategy here


We provide more than just capital when we invest. We take a board seat and play and take a hands on approach to support our companies grow. We provide scientific and commercial experience to help navigate clinical and operational hurdles.

Read more about our team here

Access to a sustainable model

Capital realised from investments is recycled onto the balance sheet to invest in new life science opportunities.

Read more about our business model here

Strong pipeline

We have access to a strong pipeline of opportunities through our global networks and partnerships. Our portfolio companies are collectively running over 20 clinical trials, which provides significant opportunity for growth

View our portfolio and pipeline here